Skip to content

Comparison of effect of spinal anaesthesia with two different drugs-Dexmedetomidine vs clonidine as premedication to spinal anaesthesia for lower abdominal and lower limb surgeries

Comparative study of intravenous clonidine versus intravenous dexmedetomidine as premedication to intrathecal 0.5% bupivacaine (hyperbaric) in patients undergoing lower abdominal and lower limb surgeries- a prospective randomised,double blind study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087696
Enrollment
56
Registered
2025-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Dexmedetomidine: Dexmedetomidine 0.5mcg/kg intravenous given as premedication to 0.5%bupivacaine(hyperbaric) Control Intervention1: Clonidine: Clonidine 0.1mcg/kg given as premedication

Sponsors

Chettinad hospital and research institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.American society of anaesthesiologist (ASA) grade I and II. 2. Scheduled for lower abdominal and lower limb surgeries. 3.Both elective and emergency procedures.

Exclusion criteria

Exclusion criteria: 1.Patient aged less than 18years and more than 60years 2.Drug allergic reaction,pregnancy,Coagulopathy,major hepatic,renal and cardiovascular dysfunction 3.Bradycardia of heart rate less than 50 beats per minute and tachycardia of heart rate more than 100 beats per minute 4.obese of BMI more than 30kilogram per meter square

Design outcomes

Primary

MeasureTime frame
To compare onset and duration of motor and sensory block To compare the duration of analgesiaTimepoint: 120 mins

Secondary

MeasureTime frame
To assess and compare the sedation score Ramsay sedation score To assess the shivering intraoperatively and postoperatively between both groups To compare the side effectsTimepoint: 120 mins

Countries

India

Contacts

Public ContactProf DR ANAND

Chettinad hospital and research institute

dranandmurugan@gmail.com9444486183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026